Tempol, a superoxide dismutase mimetic agent, reduces cisplatin-induced nephrotoxicity in rats

References

• Abdel Moneim, A.E., Othman, M.S., and Aref, A.M., 2014. Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stress. BioMed Research International, 2014, 1–11.
   Web of Science ®Google Scholar
• Ahmed, L.A., et al., 2014. Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice. PLoS One, 9 (10), e108889–e108811.
   PubMed Web of Science ®Google Scholar
• Aigner, F., et al., 2007. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. American Journal of Transplantation, 7 (4), 779–788.
   PubMed Web of Science ®Google Scholar
• Ali, B.H., et al., 2007. The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4- carboxylic acid on cisplatin-induced nephrotoxicity in rats. Fundamental and Clinical Pharmacology, 21 (5), 547–553.
   PubMed Web of Science ®Google Scholar
• Bajwa, A., et al., 2015. Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury. Journal of the American Society of Nephrology, 26 (4), 908–925.
   PubMed Web of Science ®Google Scholar
• Bhat, Z.Y., et al., 2015. Understanding the risk factors and long-term consequences of cisplatin-associated acute kidney injury: an observational cohort study. PLoS One, 10 (11), e0142225.
   PubMed Web of Science ®Google Scholar
• Chambers, J.W. and LoGrasso, P.V., 2011. Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation. Journal of Biological Chemistry, 286 (18), 16052–16062.
   PubMed Web of Science ®Google Scholar
• Chassaing, B., et al., 2012. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One, 7 (9), e44328–e44310.
   PubMed Web of Science ®Google Scholar
• Chatterjee, P.K., et al., 2000. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney International, 58 (2), 658–673.
   PubMed Web of Science ®Google Scholar
• Chirino, Y.I., et al., 2008. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology, 245 (1-2), 18–23.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea, S., et al., 2000. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion. Shock, 14 (2), 150–156.
   PubMed Web of Science ®Google Scholar
• Darwish, M.A., et al., 2017. Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation. Journal of Biochemical and Molecular Toxicology, 31 (1), e21833–e21839.
   Web of Science ®Google Scholar
• DeRubertis, F.R., Craven, P.A., and Melhem, M.F., 2007. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metabolism: Clinical and Experimental, 56 (9), 1256–1264.
   PubMed Web of Science ®Google Scholar
• Dilruba, S., and Kalayda, G.V., 2016. Platinum-based drugs: past, present and future. Cancer Chemotherapy and Pharmacology, 77 (6), 1103–1124.
   PubMed Web of Science ®Google Scholar
• Endres, M., 2006. Statins: potential new indications in inflammatory conditions. Atherosclerosis Supplements, 7 (1), 31–35.
   PubMed Web of Science ®Google Scholar
• Erbis, H., et al., 2015. Effects of tempol on experimental acute necrotizing pancreatitis model in rats. Journal of Investigative Surgery: The Official Journal of the Academy of Surgical Research, 28 (5), 268–275.
   PubMed Web of Science ®Google Scholar
• Ewees, M.G., et al., 2016. Is coenzyme Q10 effective in protection against ulcerative colitis? An experimental study in rats. Biological and Pharmaceutical Bulletin, 39 (7), 1159–1166.
   PubMed Web of Science ®Google Scholar
• Fuertes, M., et al., 2002. Novel concepts in the development of platinum antitumor drugs. Current Medicinal Chemistry-Anti-Cancer Agents, 2 (4), 539–551.
   PubMedGoogle Scholar
• Ghadermazi, R., et al., 2017. Hepatoprotective effect of tempol on oxidative toxic stress in STZ-induced diabetic rats. Toxin Reviews, 0 (0), 1–5.
   Web of Science ®Google Scholar
• Gulec, M., et al., 2006. The effects of ginkgo biloba extract on tissue adenosine deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and nitric oxide in cisplatin-induced nephrotoxicity. Toxicology and Industrial Health, 22 (3), 125–130.
   PubMed Web of Science ®Google Scholar
• Guo, P., et al., 2006. Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade. Journal of Hypertension, 24 (6), 1097–1104.
   PubMed Web of Science ®Google Scholar
• Hanigan, M.H. and Devarajan, P., 2003. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Therapy, 1, 47–61.
   PubMedGoogle Scholar
• Henry, R.J., Cannon, D. C., and Winkelman, J. W., 1974. Clinical chemistry: principles and techniques. 2nd ed. New York: Hagerstown, Md., Medical Dept., Harper & Row.
   Google Scholar
• Ho, G.Y., Woodward, N., and Coward, J.I.G., 2016. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Critical Reviews in Oncology/Hematology, 102, 37–46.
   PubMed Web of Science ®Google Scholar
• Hocher, B., et al., 2000. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. American Journal of Respiratory Cell and Molecular Biology, 23 (1), 19–26.
   PubMed Web of Science ®Google Scholar
• Hosseinian, S., et al., 2016. The protective effect of Nigella sativa against cisplatin-induced nephrotoxicity in rats. Avicenna Journal of Phytomedicine, 6 (1), 44–54.
   PubMed Web of Science ®Google Scholar
• Joy, J. and Nair, C.K.K., 2008. Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract. Journal of Cancer Research and Therapeutics, 4 (3), 111–115.
   PubMed Web of Science ®Google Scholar
• Jung, M., et al., 2009. Cisplatin upregulates mitochondrial nitric oxide synthase and peroxynitrite formation to promote renal injury. Toxicology and Applied Pharmacology, 234 (2), 236–246.
   PubMed Web of Science ®Google Scholar
• Lee, D.-H., et al., 2003. γGlutamyltransferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study. Clinical Chemistry, 49 (8), 1358–1366.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2012. Aluminum induces osteoblast apoptosis through the oxidative stress-mediated JNK signaling pathway. Biological Trace Element Research, 150 (1-3), 502–508.
   PubMed Web of Science ®Google Scholar
• Luan J., et al., 2012. Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats. Journal of Pharmacological Sciences, 119 (2), 167–176.
   PubMed Web of Science ®Google Scholar
• Maimaitiyiming, H., et al., 2013. Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function. American Journal of Renal Physiology, 305 (6), F881–F890.
   PubMed Web of Science ®Google Scholar
• Makris, K., et al., 2012. Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine. Clinical Chemistry and Laboratory Medicine, 50 (9), 1519–1532.
   PubMed Web of Science ®Google Scholar
• Manning, R.D., Tian, N., and Meng, S., 2005. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. American Journal of Nephrology, 25 (4), 311–317.
   PubMed Web of Science ®Google Scholar
• Marklund, S.L., 1985. Product of extracellular-superoxide dismutase catalysis. FEBS Letters, 184 (2), 237–239.
   PubMed Web of Science ®Google Scholar
• Miranda, K.M., Espey, M.G., and Wink, D.A., 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide, 5 (1), 62–71.
   PubMed Web of Science ®Google Scholar
• Mishra, J., et al., 2003. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology, 14 (10), 2534–2543.
   PubMed Web of Science ®Google Scholar
• Mitazaki, S., et al., 2011. Interleukin-6 plays a protective role in development of cisplatin-induced acute renal failure through upregulation of anti-oxidative stress factors. Life Sciences, 88 (25-26), 1142–1148.
   PubMed Web of Science ®Google Scholar
• Mizera, R., Hodyc, D., and Herget, J., 2015. ROS scavenger decreases basal perfusion pressure, vasoconstriction and NO synthase activity in pulmonary circulation during pulmonary microembolism. Physiological Research, 64 (5), 683–688.
   PubMed Web of Science ®Google Scholar
• Mori, K., et al., 2005. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. Journal of Clinical Investigation, 115 (3), 610–621.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, P., et al., 2010. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress and cell death in nephropathy Partha. Free Radical Biology and Medicine, 48 (3), 457–467.
   PubMed Web of Science ®Google Scholar
• Ohlsson, S., Wieslander, J., and Segelmark, M., 2003. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clinical and Experimental Immunology, 131 (3), 528–535.
   PubMed Web of Science ®Google Scholar
• Pabla, N. and Dong, Z., 2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney International, 73 (9), 994–1007.
   PubMed Web of Science ®Google Scholar
• Patschan, D., Patschan, S., and Müller, G.A., 2012. Inflammation and microvasculopathy in renal ischemia reperfusion injury. Journal of Transplantation, 2012, 1–7.
   Google Scholar
• Patton, C.J. and Crouch, S.R., 1977. Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Analytical Chemistry, 49 (3), 464–469.
   Web of Science ®Google Scholar
• Perl, M., et al., 2011. Pathogenesis of indirect (secondary) acute lung injury. Expert Review of Respiratory Medicine, 5 (1), 115–126.
   PubMed Web of Science ®Google Scholar
• Quiros, Y., et al., 2010. Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein. Kidney International, 78 (10), 1006–1015.
   PubMed Web of Science ®Google Scholar
• Ranjbar, A., et al., 2016. Tempol effects on diabetic nephropathy in male rats. Journal of Renal Injury Prevention, 5 (2), 74–78.
   PubMed Web of Science ®Google Scholar
• Roudkenar, M.H., et al., 2007. Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. Journal of Radiation Research, 48 (1), 39–44.
   PubMed Web of Science ®Google Scholar
• Saleh, R.M., et al., 2014. Renal and cardiovascular damage induced by cisplatin in rats. Life Science Journal, 11 (2), 191–203.
   Google Scholar
• Schwartz, N., Michaelson, J.S., and Putterman, C., 2007. Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis. Annals of the New York Academy of Sciences, 1109, 265–274.
   PubMed Web of Science ®Google Scholar
• Sedlak, J. and Lindsay, R.H., 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical Biochemistry, 25, 192–205.
   PubMed Web of Science ®Google Scholar
• Sharma, J.N., Al-Omran, A., and Parvathy, S.S., 2007. Role of nitric oxide in inflammatory diseases. Inflammopharmacology, 15 (6), 252–259.
   PubMedGoogle Scholar
• Siddik, Z.H., 2003. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 22 (47), 7265–7279.
   PubMed Web of Science ®Google Scholar
• Simonsen, U., et al., 2009. Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation. Pharmacological Reports, 61 (1), 105–115.
   PubMed Web of Science ®Google Scholar
• Tanabe, K., et al., 2012. Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy. AJP: Renal Physiology, 303 (9), F1264–F1274.
   Google Scholar
• Taye, A., Abouzied, M.M., and Mohafez, O.M.M., 2013. Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy. Naunyn-Schmiedeberg's Archives of Pharmacology, 386 (12), 1071–1080.
   PubMed Web of Science ®Google Scholar
• Türk, G., et al., 2008. Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid. Fertility and Sterility, 89 (5), 1474–1481 (SUPPL.).
   PubMed Web of Science ®Google Scholar
• Uchiyama, M. and Mihara, M., 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry, 86 (1), 271–278.
   PubMed Web of Science ®Google Scholar
• Vaziri, N.D., et al., 2003. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney International, 63 (1), 179–185.
   PubMed Web of Science ®Google Scholar
• Wang, D. and Lippard, S.J., 2005. Cellular processing of platinum anticancer drugs. Nature Reviews. Drug Discovery, 4 (4), 307–320.
   PubMed Web of Science ®Google Scholar
• Wilcox, C.S., 2010. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacology and Therapeutics, 126 (2), 119–145.
   PubMed Web of Science ®Google Scholar
• Wilcox, C.S. and Pearlman, A., 2008. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacological Reviews, 60 (4), 418–469.
   PubMed Web of Science ®Google Scholar
• Xu, G., et al., 2012. Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation. Journal of Biological Chemistry, 287 (7), 4808–4817.
   PubMed Web of Science ®Google Scholar
• Yang, F., et al., 2015. Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to cisplatin. BMB Reports, 48 (1), 30–35.
   PubMed Web of Science ®Google Scholar
• Yao, X., et al., 2007. Cisplatin nephrotoxicity: a review. The American Journal of the Medical Sciences, 334 (2), 115–124.
   PubMed Web of Science ®Google Scholar
• Zhang, G., et al., 2016. Protective effect of tempol on acute kidney injury through PI3K/Akt/Nrf2 signaling pathway. Kidney and Blood Pressure Research, 41 (2), 129–138.
   PubMed Web of Science ®Google Scholar
• Zsengellér, Z.K., et al., 2012. Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity. Journal of Histochemistry & Cytochemistry, 60 (7), 521–529.
   PubMed Web of Science ®Google Scholar